Ketamine analogue (MIRA Pharmaceuticals)

N/A

Report date: 2025/08/13 14:02:50
NME

Base Information

Drug NameKetamine analogue (MIRA Pharmaceuticals)
Drug Alias NameKetamir-2
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantDepressive DisorderNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMIRA Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesFormulexMIRA Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-ResistantDepressive DisorderNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A